肿瘤生长速率不能预测Bethesda III类伴结构异型性甲状腺结节的恶性风险
该回顾性单中心队列研究纳入172例因细胞学诊断为AUS-A而接受诊断性甲状腺手术的患者,术前超声随访中位52.6个月。病理显示112例(65%)良性、60例(35%)恶性;良恶性结节的最大径和体积均逐渐增大,但生长速率无显著差异。结论认为连续术前超声的生长动力学不能预测AUS-A亚类的恶性风险。
要点
- AUS-A结节无论良恶性,最大径和体积均随时间逐渐增大(p < 0.001)。
- 良恶性结节基于最大径(p = 0.132)和体积(p = 0.200)的生长速率无显著差异。
- 生长结节与稳定结节的恶性相对风险无显著差异(最大径RR = 0.5,p = 0.064;体积RR = 0.9,p = 0.748)。
核心结论
- AUS-A甲状腺结节无论良恶性,其大小均呈线性增长。
- 连续术前颈部超声评估的生长动力学不能预测AUS-A亚类的恶性风险。
研究设计与样本
- 回顾性、单中心队列研究,纳入172例因细胞学诊断为AUS-A而接受诊断性甲状腺手术的患者。
- 通过术前连续颈部超声评估结节生长动力学,中位随访52.6个月(范围12.7-198.3个月)。
主要发现
- 病理检查显示112例(65%)为良性结节,60例(35%)为恶性结节。
- 良性和恶性结节的最大径及体积均逐渐增大(p < 0.001)。
- 良恶性结节基于最大径的生长速率无显著差异(p = 0.132),基于体积的生长速率亦无显著差异(p = 0.200)。
- 恶性结节与良性结节相比,肿瘤生长曲线时间(p = 0.458)和估计中位显著生长时间(p = 0.568)均无显著差异。
- 生长结节与稳定结节的恶性相对风险基于最大径(RR = 0.5;p = 0.064)和体积(RR = 0.9;p = 0.748)均无显著差异。
临床怎么用
- 对于细胞学为AUS-A的甲状腺结节,不应仅依据超声生长速率来判断恶性风险。
- 临床决策需结合其他超声特征、细胞学及分子检测等综合评估,而非依赖生长动力学。
局限性
- 回顾性单中心设计可能存在选择偏倚。
- 仅纳入接受手术的患者,可能存在转诊偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is unknown whether the growth of thyroid nodules with a Bethesda category III cytology (atypia of undetermined significance [AUS]) is predictive of malignancy, especially in cases with architectural atypia (AUS-A). This study evaluated whether tumor growth rates can help distinguish malignant from benign nodules in the AUS-A subcategory. METHODS: This retrospective, single-center cohort study included 172 patients who underwent diagnostic thyroid surgery because of a nodule with a cytological diagnosis of AUS-A. The growth kinetics of nodules was assessed by serial preoperative neck ultrasonography over a median follow-up of 52.6 months (range 12.7-198.3 months). RESULTS: Pathologic examinations showed that 112 (65%) and 60 (35%) patients had benign and malignant nodules, respectively. The largest diameter and volume of both benign and malignant nodules increased gradually (p < 0.001). However, there was no significant difference in the growth rates of benign and malignant nodules based on the largest diameter (p = 0.132) and volume (p = 0.200). The time to tumor growth curves and estimated median time to significant tumor growth from baseline were not significantly different in malignant nodules compared to benign nodules (p = 0.458 and p = 0.568, respectively). The relative risk (RR) of malignancy of growing and stable nodules did not differ significantly based on the largest diameter (RR = 0.5; p = 0.064) and volume (RR = 0.9; p = 0.748). CONCLUSIONS: The size of thyroid nodules classified as AUS-A increased linearly, regardless whether these nodules were benign or malignant. These results suggest that growth kinetics on serial preoperative neck ultrasonography cannot predict malignancy in the AUS-A subcategory.
引用
- Kim M, Jeon MJ, Han M, et al. Tumor Growth Rate Does Not Predict Malignancy in Surgically Resected Thyroid Nodules Classified as Bethesda Category III with Architectural Atypia. Thyroid. 2018. PMID: 30421654. doi:10.1089/thy.2018.0366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。